Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget, 6247-6248 [07-577]
Download as PDF
6247
Federal Register / Vol. 72, No. 27 / Friday, February 9, 2007 / Notices
There are no costs to the respondents
other than their time. The total
estimated annualized burden hours are
234.
Type of responses or kinds of respondents
Number of respondents
Number of responses per
respondent
Average burden per response (in
hours)
Semi-Annual Report ....................................................................................................................
13
2
9
Dated: February 5, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–2177 Filed 2–8–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare and Medicaid
Services
[Document Identifier: CMS–R–262 and
CMS–10142]
Emergency Clearance: Public
Information Collection Requirements
Submitted to the Office of Management
and Budget
Center for Medicare and
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare and Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
We are, however, requesting an
emergency review of the information
collection referenced below. In
compliance with the requirement of
section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, we have
submitted to the Office of Management
and Budget (OMB) the following
requirements for emergency review. We
are requesting an emergency review
because the collection of this
information is needed before the
jlentini on PROD1PC65 with NOTICES
AGENCY:
VerDate Aug<31>2005
21:06 Feb 08, 2007
Jkt 211001
expiration of the normal time limits
under OMB’s regulations at 5 CFR Part
1320. This is necessary to ensure
compliance with an initiative of the
Administration. CMS does not have
sufficient time to complete the normal
PRA clearance process while making
corrections and enhancements to the
software and ensuring that organizations
have ample time to complete and
submit their tools by the statutory
deadline in June 2007. The normal PRA
clearance process would result in
violating this statutory deadline which
would prevent Medicare Advantage
(MA) and Prescription Drug Plan (PDP)
organizations from providing benefits to
millions of Medicare beneficiaries.
CMS is requesting to continue its use
of the Plan Benefit Package software,
formulary and Bid Pricing Tool for the
collection of benefits, pricing and
related information for CY 2008 as part
of the annual bidding process.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Plan Benefit
Package (PBP) and Formulary
Submission for Medicare Advantage
(MA) Plans and Prescription Drug Plans
(PDPs); Use: Under the Medicare
Modernization Act (MMA), Medicare
Advantage (MA) and Prescription Drug
Plan (PDP) organizations are required to
submit plan benefit packages for all
Medicare beneficiaries residing in their
service area. CMS requires that MA and
PDP organizations submit a completed
formulary and PBP as part of the annual
bidding process. During this process,
organizations prepare their proposed
plan benefit packages for the upcoming
contract year and submit them to CMS
for review and approval. The changes to
the PBP include enhancements to the
software for describing the out-ofnetwork benefits, Medicare Savings
Account (MSA) benefits, Point of
Service (POS) benefits, Visitor/Travel
benefits, and collecting Medicare Rx
information on gap coverage. The
changes to the formulary include
enhancements to the submission
process by developing a drug reference
table and by collecting excluded drug
indicators, specialty drug indicators,
and drug types. The software is more
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
clarifying for the plans to describe its
benefits and for the beneficiaries to
understand their coverage; Form
Number: CMS–R–262 (OMB#: 0938–
0763); Frequency: Yearly; Affected
Public: Business or other for-profit and
Not-for-profit institutions; Number of
Respondents: 450; Total Annual
Responses: 4,725; Total Annual Hours:
10,800.
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Bid Pricing Tool
(BPT) for Medicare Advantage (MA)
Plans and Prescription Drug Plans
(PDPs); Use: Under the Medicare
Prescription Drug, Improvement, and
Modernization (MMA), Medicare
Advantage organizations (MAO) and
Prescription Drug Plans (PDP) are
required to submit an actuarial pricing
‘‘bid’’ for each plan offered to Medicare
beneficiaries. CMS requires that MAOs
and PDPs complete the BPT as part of
the annual bidding process. During this
process, organizations prepare their
proposed actuarial bid pricing for the
upcoming contract year and submit
them to CMS for review and approval.
The purpose of the BPT is to collect the
actuarial pricing information for each
plan. The BPT calculates the plan’s bid,
enrollee premiums, and payment rates.
The BPT revisions include structural
changes to the MA worksheets and
changes to streamline reporting
requirements. Form Number: CMS–
10142 (OMB#: 0938–0944); Frequency:
Yearly; Affected Public: Business or
other for-profit and Not-for-profit
institutions; Number of Respondents:
550; Total Annual Responses: 6,050;
Total Annual Hours: 42,350.
CMS is requesting OMB review and
approval of these collections by March
21, 2007, with a 180-day approval
period. Written comments and
recommendation will be considered
from the public if received by the
individuals designated below by March
3, 2007.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995 or E-
E:\FR\FM\09FEN1.SGM
09FEN1
6248
Federal Register / Vol. 72, No. 27 / Friday, February 9, 2007 / Notices
mail your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
Interested persons are invited to send
comments regarding the burden or any
other aspect of these collections of
information requirements. However, as
noted above, comments on these
information collection and
recordkeeping requirements must be
mailed and/or faxed to the designees
referenced below by March 3, 2007:
Centers for Medicare and Medicaid
Services, Office of Strategic
Operations and Regulatory Affairs,
Room C4–26–05, 7500 Security
Boulevard,Baltimore, MD 21244–
1850, Attn: Bonnie L Harkless; and,
OMB Human Resources and Housing
Branch, Attention: Carolyn Lovett,
New Executive Office Building, Room
10235, Washington, DC 20503.
Dated: February 2, 2007.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. 07–577 Filed 2–8–07; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
jlentini on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Center
Review Committee.
Date: February 19, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
VerDate Aug<31>2005
21:06 Feb 08, 2007
Jkt 211001
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1388, rliu@nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDA/
L Conflicts.
Date: March 5, 2007.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Metro Center, 775 12th
Street NW., Washington, DC 20005.
Contact Person: Mark R. Green PhD,
Deputy Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1431, mgreen1@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDA–
F Conflicts.
Date: March 6, 2007.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Boulevard, Bethesda,
MD 20892–8401, (301) 402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDA–
E Conflicts.
Date: March 6–7, 2007.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Blvd., Bethesda, MD
20892–8401, (301) 402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel NIDA/K
Conflicts.
Date: March 13, 2007.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel, 8120 Wisconsin
Ave., Bethesda, MD 20814.
Contact Person: Mark Swieter, PhD, Chief,
Training and Special Projects Review Branch,
Office of Extramural Affairs, National
Institute on Drug Abuse, NIH, DHHS, 6101
Executive Boulevard, Suite 220, Bethesda,
MD 20892–7491, (301) 435–1389,
ms80x@nih.gov.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addition Research Programs, National
Institutes of Health, HHS)
Dated: February 5, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–592 Filed 2–8–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[FEMA–3270–EM]
Colorado; Amendment No. 2 to Notice
of an Emergency Declaration
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice amends the notice
of an emergency declaration for the
State of Colorado (FEMA–3270-EM),
dated January 7, 2007, and related
determinations.
DATES: Effective Date: January 31, 2007.
FOR FURTHER INFORMATION CONTACT:
Magda Ruiz, Recovery Division, Federal
Emergency Management Agency,
Washington, DC 20472, (202) 646–2705.
SUPPLEMENTARY INFORMATION: The notice
of an emergency declaration for the
State of Colorado is hereby amended to
include the following area among those
areas determined to have been adversely
affected by the catastrophe declared an
emergency by the President in his
declaration of January 7, 2007:
Teller County for emergency protective
measures (Category B), including snow
removal, under the Public Assistance
program for any continuous 48-hour period
during or proximate to the incident period.
(The following Catalog of Federal Domestic
Assistance Numbers (CFDA) are to be used
for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora
Brown Fund Program; 97.032, Crisis
Counseling; 97.033, Disaster Legal Services
Program; 97.034, Disaster Unemployment
Assistance (DUA); 97.046, Fire Management
Assistance; 97.048, Individuals and
Households Housing; 97.049, Individuals and
Households Disaster Housing Operations;
97.050 Individuals and Households
Program—Other Needs; 97.036, Public
Assistance Grants; 97.039, Hazard Mitigation
Grant Program.)
R. David Paulison,
Under Secretary for Federal Emergency
Management and Director of FEMA.
[FR Doc. E7–2145 Filed 2–8–07; 8:45 am]
BILLING CODE 9110–10–P
E:\FR\FM\09FEN1.SGM
09FEN1
Agencies
[Federal Register Volume 72, Number 27 (Friday, February 9, 2007)]
[Notices]
[Pages 6247-6248]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-577]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare and Medicaid Services
[Document Identifier: CMS-R-262 and CMS-10142]
Emergency Clearance: Public Information Collection Requirements
Submitted to the Office of Management and Budget
AGENCY: Center for Medicare and Medicaid Services.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid
Services (CMS), Department of Health and Human Services, is publishing
the following summary of proposed collections for public comment.
Interested persons are invited to send comments regarding this burden
estimate or any other aspect of this collection of information,
including any of the following subjects: (1) The necessity and utility
of the proposed information collection for the proper performance of
the agency's functions; (2) the accuracy of the estimated burden; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
We are, however, requesting an emergency review of the information
collection referenced below. In compliance with the requirement of
section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have
submitted to the Office of Management and Budget (OMB) the following
requirements for emergency review. We are requesting an emergency
review because the collection of this information is needed before the
expiration of the normal time limits under OMB's regulations at 5 CFR
Part 1320. This is necessary to ensure compliance with an initiative of
the Administration. CMS does not have sufficient time to complete the
normal PRA clearance process while making corrections and enhancements
to the software and ensuring that organizations have ample time to
complete and submit their tools by the statutory deadline in June 2007.
The normal PRA clearance process would result in violating this
statutory deadline which would prevent Medicare Advantage (MA) and
Prescription Drug Plan (PDP) organizations from providing benefits to
millions of Medicare beneficiaries.
CMS is requesting to continue its use of the Plan Benefit Package
software, formulary and Bid Pricing Tool for the collection of
benefits, pricing and related information for CY 2008 as part of the
annual bidding process.
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Plan Benefit
Package (PBP) and Formulary Submission for Medicare Advantage (MA)
Plans and Prescription Drug Plans (PDPs); Use: Under the Medicare
Modernization Act (MMA), Medicare Advantage (MA) and Prescription Drug
Plan (PDP) organizations are required to submit plan benefit packages
for all Medicare beneficiaries residing in their service area. CMS
requires that MA and PDP organizations submit a completed formulary and
PBP as part of the annual bidding process. During this process,
organizations prepare their proposed plan benefit packages for the
upcoming contract year and submit them to CMS for review and approval.
The changes to the PBP include enhancements to the software for
describing the out-of-network benefits, Medicare Savings Account (MSA)
benefits, Point of Service (POS) benefits, Visitor/Travel benefits, and
collecting Medicare Rx information on gap coverage. The changes to the
formulary include enhancements to the submission process by developing
a drug reference table and by collecting excluded drug indicators,
specialty drug indicators, and drug types. The software is more
clarifying for the plans to describe its benefits and for the
beneficiaries to understand their coverage; Form Number: CMS-R-262
(OMB: 0938-0763); Frequency: Yearly; Affected Public: Business
or other for-profit and Not-for-profit institutions; Number of
Respondents: 450; Total Annual Responses: 4,725; Total Annual Hours:
10,800.
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Bid Pricing Tool
(BPT) for Medicare Advantage (MA) Plans and Prescription Drug Plans
(PDPs); Use: Under the Medicare Prescription Drug, Improvement, and
Modernization (MMA), Medicare Advantage organizations (MAO) and
Prescription Drug Plans (PDP) are required to submit an actuarial
pricing ``bid'' for each plan offered to Medicare beneficiaries. CMS
requires that MAOs and PDPs complete the BPT as part of the annual
bidding process. During this process, organizations prepare their
proposed actuarial bid pricing for the upcoming contract year and
submit them to CMS for review and approval. The purpose of the BPT is
to collect the actuarial pricing information for each plan. The BPT
calculates the plan's bid, enrollee premiums, and payment rates. The
BPT revisions include structural changes to the MA worksheets and
changes to streamline reporting requirements. Form Number: CMS-10142
(OMB: 0938-0944); Frequency: Yearly; Affected Public: Business
or other for-profit and Not-for-profit institutions; Number of
Respondents: 550; Total Annual Responses: 6,050; Total Annual Hours:
42,350.
CMS is requesting OMB review and approval of these collections by
March 21, 2007, with a 180-day approval period. Written comments and
recommendation will be considered from the public if received by the
individuals designated below by March 3, 2007.
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS'
Web Site address at https://www.cms.hhs.gov/PaperworkReductionActof1995
or E-
[[Page 6248]]
mail your request, including your address, phone number, OMB number,
and CMS document identifier, to Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786-1326.
Interested persons are invited to send comments regarding the
burden or any other aspect of these collections of information
requirements. However, as noted above, comments on these information
collection and recordkeeping requirements must be mailed and/or faxed
to the designees referenced below by March 3, 2007:
Centers for Medicare and Medicaid Services, Office of Strategic
Operations and Regulatory Affairs, Room C4-26-05, 7500 Security
Boulevard,Baltimore, MD 21244-1850, Attn: Bonnie L Harkless; and,
OMB Human Resources and Housing Branch, Attention: Carolyn Lovett, New
Executive Office Building, Room 10235, Washington, DC 20503.
Dated: February 2, 2007.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations
and Regulatory Affairs.
[FR Doc. 07-577 Filed 2-8-07; 8:45 am]
BILLING CODE 4120-01-P